Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Study of LY3127804 in Participants With COVID-19

ClinicalTrials.gov ID: NCT04342897

Public ClinicalTrials.gov record NCT04342897. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 4:27 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Clinical Trial of LY3127804 in Patients Who Are Hospitalized With Pneumonia and Presumed or Confirmed COVID-19

Study identification

NCT ID
NCT04342897
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
95 participants

Conditions and interventions

Interventions

  • LY3127804 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 19, 2020
Primary completion
Oct 11, 2020
Completion
Oct 11, 2020
Last update posted
Aug 11, 2021

2020

United States locations

U.S. sites
13
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
Banner Univ Med Ctr Phoenix Phoenix Arizona 85006
Banner Univ Med Ctr Tucson Tucson Arizona 85719
National Jewish Medical and Research Center Denver Colorado 80206
Nuvance Danbury Hospital Danbury Connecticut 06810
NorthShore University HealthSystem Evanston Illinois 60201
Parkview Research Center Fort Wayne Indiana 46845
Franciscan St. Francis Health Indianapolis Indiana 46237
Ochsner Clinic Foundation New Orleans Louisiana 70121
Lahey Hospital and Medical Center Burlington Massachusetts 01805
Henry Ford Hospital Detroit Detroit Michigan 48202-2689
Allina Hospital Network Minneapolis Minnesota 55404
State University of New York Hospital Syracuse New York 13210
East Carolina University Greenville North Carolina 27834

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04342897, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 11, 2021 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04342897 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →